The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus
Open accessAbstract
Background: Clinical lipid measurements do not show the full complexity of the altered lipid metabolism associated with diabetes mellitus or cardiovascular disease. Lipidomics enables the assessment of hundreds of lipid species as potential markers for disease risk. Methods: Plasma lipid species (310) were measured by a targeted lipidomic analysis with liquid chromatography electrospray ionization–tandem mass spectrometry on a case-cohort (n=3779) subset from the ADVANCE trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation). The case-cohort was 61% male with a mean age of 67 years. All participants had type 2 diabetes mellitus with ≥1 additional cardiovascular risk factors, and 35% had a history of macrovascular disease. Weighted Cox regression was used to identify lipid species associated with future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) and cardiovascular death during a 5-year follow-up period. Multivariable models combining traditional risk factors with lipid species were optimized with the Akaike information criteria. C statistics and NRIs were calculated within a 5-fold cross-validation framework. Results: Sphingolipids, phospholipids (including lyso- and ether- species), cholesteryl esters, and glycerolipids were associated with future cardiovascular events and cardiovascular death. The addition of 7 lipid species to a base model (14 traditional risk factors and medications) to predict cardiovascular events increased the C statistic from 0.680 (95% confidence interval [CI], 0.678–0.682) to 0.700 (95% CI, 0.698–0.702; P <0.0001) with a corresponding continuous NRI of 0.227 (95% CI, 0.219–0.235). The prediction of cardiovascular death was improved with the incorporation of 4 lipid species into the base model, showing an increase in the C statistic from 0.740 (95% CI, 0.738–0.742) to 0.760 (95% CI, 0.757–0.762; P <0.0001) and a continuous net reclassification index of 0.328 (95% CI, 0.317–0.339). The results were validated in a subcohort with type 2 diabetes mellitus (n=511) from the LIPID trial (Long-Term Intervention With Pravastatin in Ischemic Disease). Conclusions: The improvement in the prediction of cardiovascular events, above traditional risk factors, demonstrates the potential of plasma lipid species as biomarkers for cardiovascular risk stratification in diabetes mellitus. Clinical Trial Registration: URL: https://clinicaltrials.gov . Unique identifier: NCT00145925.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Jolliffe, I. (2005) · Encyclopedia of Statistics in Behavioral Science · doi:10.1002/0470013192.bsa501 · Cited by 14,310
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Chiang, L. H., Russell, E. L., & Braatz, R. D. (2001) · Advanced Textbooks in Control and Signal Processing · doi:10.1007/978-1-4471-0347-9_4 · Cited by 6,594
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Self-citationExtensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
(2002) · Springer Series in Statistics · doi:10.1007/b98835 · Cited by 919
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
Stegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.002500 · Cited by 564
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Adkins, Y., & Kelley, D. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.004 · Cited by 557
Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D
Newson, R. B. (2010) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1001000303 · Cited by 424
Plasma lipid profiling in a large population-based cohort
Weir, J. M., Wong, G., Barlow, C. K., Greeve, M. A., Kowalczyk, A., Almasy, L., Comuzzie, A. G., Mahaney, M. C., Jowett, J. B. M., Shaw, J., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p035808 · Cited by 366
Self-citationKeech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R. J., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2713 · Cited by 313
Self-citationPlasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes
Meikle, P. J., Wong, G., Barlow, C. K., Weir, J. M., Greeve, M. A., MacIntosh, G. L., Almasy, L., Comuzzie, A. G., Mahaney, M. C., Kowalczyk, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074341 · Cited by 308
Self-citationPlasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease
Meikle, P. J., Wong, G., Tsorotes, D., Barlow, C. K., Weir, J. M., Christopher, M. J., MacIntosh, G. L., Goudey, B., Stern, L., Kowalczyk, A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234096 · Cited by 306
Self-citationLeßig, J., & Fuchs, B. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682164 · Cited by 220
An Efficient Single Phase Method for the Extraction of Plasma Lipids
Alshehry, Z., Barlow, C., Weir, J., Zhou, Y., McConville, M., & Meikle, P. (2015) · Metabolites · doi:10.3390/metabo5020389 · Cited by 218
Self-citationComparative Lipidomics Profiling of Human Atherosclerotic Plaques
Stegemann, C., Drozdov, I., Shalhoub, J., Humphries, J., Ladroue, C., Didangelos, A., Baumert, M., Allen, M., Davies, A. H., Monaco, C., et al. (2011) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.959098 · Cited by 209
Coleman, R. L., Stevens, R. J., Retnakaran, R., & Holman, R. R. (2007) · Diabetes Care · doi:10.2337/dc06-1358 · Cited by 193
Marathe, G. K., Davies, S. S., Harrison, K. A., Silva, A. R., Murphy, R. C., Castro-Faria-Neto, H., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28395 · Cited by 187
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes
Kengne, A. P., Patel, A., Marre, M., Travert, F., Lievre, M., Zoungas, S., Chalmers, J., Colagiuri, S., Grobbee, D. E., Hamet, P., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710394270 · Cited by 183
Self-citationNot Available, N. A., & Committee, A. M. (2001) · Diabetologia · doi:10.1007/s001250100612 · Cited by 180
Cardiovascular risk assessment scores for people with diabetes: a systematic review
Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1454-0 · Cited by 176
Gangliosides in normal human serum: Concentration, pattern and transport by lipoproteins
SENN, H., ORTH, M., FITZKE, E., WIELAND, H., & GEROK, W. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14773.x · Cited by 160
for the ADVANCE Collaborative Group, Kengne, A. P., Patel, A. A., Colagiuri, S., Heller, S. R., Hamet, P., Marre, M., Pan, C., Zoungas, S., Grobbee, D. E., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1681-4 · Cited by 141
Self-citationHonsho, M., Asaoku, S., & Fujiki, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083311 · Cited by 128
Chatterjee, S. B., Bedja, D., Mishra, S., Amuzie, C., Avolio, A. P., Kass, D. A., Berkowitz, D. E., & Renehan, M. (2014) · Circulation · doi:10.1161/circulationaha.113.007559 · Cited by 109
Chang, C. L., & Deckelbaum, R. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283616364 · Cited by 81
Topogenesis and Homeostasis of Fatty Acyl-CoA Reductase 1
Honsho, M., Asaoku, S., Fukumoto, K., & Fujiki, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498345 · Cited by 77
Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice
Rasmiena, A. A., Barlow, C. K., Stefanovic, N., Huynh, K., Tan, R., Sharma, A., Tull, D., de Haan, J. B., & Meikle, P. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.096 · Cited by 66
Self-citationWallentin, L. C., Held, C., Armstrong, P. W., Cannon, C. P., Davies, R. Y., Granger, C. B., Hagström, E., Harrington, R. A., Hochman, J. S., Köenig, W., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003407 · Cited by 66
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Garner, B., Priestman, D. A., Stocker, R., Harvey, D. J., Butters, T. D., & Platt, F. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30162-0 · Cited by 60
Davis, W. A., Colagiuri, S., & Davis, T. M. E. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02343.x · Cited by 59
Davis, W. A., Colagiuri, S., & Davis, T. M. E. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02684.x · Cited by 55
Dohi, T., Miyauchi, K., Okazaki, S., Yokoyama, T., Ohkawa, R., Nakamura, K., Yanagisawa, N., Tsuboi, S., Ogita, M., Yokoyama, K., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.019 · Cited by 32
Cited by
Structural and functional roles of ether lipids
Dean, J. M., & Lodhi, I. J. (2018) · Protein & Cell · doi:10.1007/s13238-017-0423-5 · Cited by 672
The Mediterranean diet, plasma metabolome, and cardiovascular disease risk
Li, J., Guasch-Ferré, M., Chung, W., Ruiz-Canela, M., Toledo, E., Corella, D., Bhupathiraju, S. N., Tobias, D. K., Tabung, F. K., Hu, J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa209 · Cited by 359
Burla, B., Arita, M., Arita, M., Bendt, A. K., Cazenave-Gassiot, A., Dennis, E. A., Ekroos, K., Han, X., Ikeda, K., Liebisch, G., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.s087163 · Cited by 312
Self-citationCardiomyopathy in obesity, insulin resistance and diabetes
Nakamura, M., & Sadoshima, J. (2020) · The Journal of Physiology · doi:10.1113/jp276747 · Cited by 286
Analytical Challenges and Recent Advances in Mass Spectrometry Based Lipidomics
Rustam, Y. H., & Reid, G. E. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04836 · Cited by 282
Metadata
- Authors
- Alshehry, Z. H., Mundra, P. A., Barlow, C. K., Mellett, N. A., Wong, G., McConville, M. J., Simes, J., Tonkin, A. M., Sullivan, D. R., Barnes, E. H., Nestel, P. J., Kingwell, B. A., Marre, M., Neal, B., Poulter, N. R., Rodgers, A., Williams, B., Zoungas, S., Hillis, G. S., Chalmers, J., Woodward, M., & Meikle, P. J.
- Venue
- Circulation
- Published
- 2016-11-22
- Volume
- 134
- Issue
- 21
- Pages
- 1637-1650
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2538517030
- Cited by
- 268
- References
- 46
- FWCI
- 19.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.